Found 349 bookmarks
Newest
2023 AAAP & ASAM Stimulant Use Disorder (StUD) Clinical Guideline Summary
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjtsKL2te-EAxV0vokEHVgGDMUQFnoECEUQAQ&url=https%3A%2F%2Fwww.moh.gov.my%2Fmoh%2Fresources%2FPenerbitan%2FCPG%2FPsychiatry%2520%26%2520Mental%2520health%2FCPG_Management_of_Attention-Deficit_Hyperactivity_Disorder_(Second_Edition)_06072021.pdf&usg=AOvVaw1MYMsEZBGWiVJAzF-DN9ye&opi=89978449
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjtsKL2te-EAxV0vokEHVgGDMUQFnoECEUQAQ&url=https%3A%2F%2Fwww.moh.gov.my%2Fmoh%2Fresources%2FPenerbitan%2FCPG%2FPsychiatry%2520%26%2520Mental%2520health%2FCPG_Management_of_Attention-Deficit_Hyperactivity_Disorder_(Second_Edition)_06072021.pdf&usg=AOvVaw1MYMsEZBGWiVJAzF-DN9ye&opi=89978449
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjtsKL2te-EAxV0vokEHVgGDMUQFnoECEUQAQ&url=https%3A%2F%2Fwww.moh.gov.my%2Fmoh%2Fresources%2FPenerbitan%2FCPG%2FPsychiatry%2520%26%2520Mental%2520health%2FCPG_Management_of_Attention-Deficit_Hyperactivity_Disorder_(Second_Edition)_06072021.pdf&usg=AOvVaw1MYMsEZBGWiVJAzF-DN9ye&opi=89978449
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjtsKL2te-EAxV0vokEHVgGDMUQFnoECF8QAQ&url=https%3A%2F%2Fwww.clinicaltherapeutics.com%2Farticle%2FS0149-2918(20)30283-6%2Fpdf&usg=AOvVaw1ed5vDgqHHdcwpdXFf41CW&opi=89978449
Childhood ADHD: Biological Reality or Social Construction, with Policy Implications | Raising Children: Emerging Needs, Modern Risks, and Social Responses | Oxford Academic
Childhood ADHD: Biological Reality or Social Construction, with Policy Implications | Raising Children: Emerging Needs, Modern Risks, and Social Responses | Oxford Academic
Abstract. One of the greatest challenges that parents confront in raising children involves monitoring their health and managing to obtain the proper treatment
·academic.oup.com·
Childhood ADHD: Biological Reality or Social Construction, with Policy Implications | Raising Children: Emerging Needs, Modern Risks, and Social Responses | Oxford Academic
Childhood ADHD: Biological Reality or Social Construction, with Policy Implications | Raising Children: Emerging Needs, Modern Risks, and Social Responses | Oxford Academic
Childhood ADHD: Biological Reality or Social Construction, with Policy Implications | Raising Children: Emerging Needs, Modern Risks, and Social Responses | Oxford Academic
Abstract. One of the greatest challenges that parents confront in raising children involves monitoring their health and managing to obtain the proper treatment
·academic.oup.com·
Childhood ADHD: Biological Reality or Social Construction, with Policy Implications | Raising Children: Emerging Needs, Modern Risks, and Social Responses | Oxford Academic
ADHD: relation between cognitive characteristics and DAT1 / DRD4 dopamine polymorphisms | bioRxiv
ADHD: relation between cognitive characteristics and DAT1 / DRD4 dopamine polymorphisms | bioRxiv
Attention deficit hyperactivity disorder (ADHD) is a clinical and diagnostic heterogeneous picture. This study analysed the association of functional polymorphisms in DAT1 VNTR 3’ UTR and DRD4 VNTR Exon III candidate genes, and the neuropsychological characterisation of attention and executive functions of a group of children with ADHD vs. controls. 32 patients and 51 controls were selected. The DAT1 10-repeat allele appeared more frequently in the two groups (cases: 0.93/control: 0.82), showing an OR: 2.5 (IC 95%: 0.684-9.133; p: 0.158). In DRD4, the 4-repeat allele shows the highest occurrence (cases: 0.62/controls: 0.60). None of the markers presented a significant association after a direct analysis, but the DRD4 7-repeat marker showed a positive risk when performing a Bayesian logistic analysis (coefficient: −1.69; OR: 5.39 CI 95%: 1.167-40.97). On the other hand, when considering association with cognitive performance, a positive risk for processing speed and attention tasks was identified.
·biorxiv.org·
ADHD: relation between cognitive characteristics and DAT1 / DRD4 dopamine polymorphisms | bioRxiv
Stimulant Guide | Feature Topics | Drug Overdose
Pharmacological interventions for traumatic brain injury | British Columbia Medical Journal
Pharmacological interventions for traumatic brain injury | British Columbia Medical Journal
Traumatic brain injury (TBI) is commonly defined as an insult to the brain from an external force that causes temporary or permanent impairment in functional, psychosocial, or physical abilities.1 It is a significant cause of morbidity and mortality, and the leading cause of death and disability among young adults.
·bcmj.org·
Pharmacological interventions for traumatic brain injury | British Columbia Medical Journal
The drug treatment of delayed ejaculation - Abdel-Hamid - Translational Andrology and Urology
JMIR Formative Research - An Emotional Bias Modification for Children With Attention-Deficit/Hyperactivity Disorder: Co-design Study
JMIR Formative Research - An Emotional Bias Modification for Children With Attention-Deficit/Hyperactivity Disorder: Co-design Study
Background: Attention-deficit/hyperactivity disorder (ADHD) is one of the common neurodevelopment disorders. Children with ADHD typically have difficulties with emotional regulation. Previous studies have investigated the assessment for underlying emotional biases using the visual probe task. However, one of the significant limitations of the visual probe task is that it is demanding and repetitive over time. Previous studies have examined the use of gamification methods in addressing the limitations of the emotional bias visual probe task. There has also been increased recognition of the potential of participatory action research methods and how it could help to make the conceptualized interventions more relevant. Objective: The primary aim of this study was to collate health care professionals’ perspectives on the limitations of the existing visual probe task and to determine if gamification elements were viable to be incorporated into an emotional bias modification task. Methods: A co-design workshop was conducted. Health care professionals from the Department of Development Psychiatry, Institute of Mental Health, Singapore, were invited to participate. Considering the COVID-19 pandemic and the restrictions, a web-based workshop was conducted. There were 3 main phases in the workshops. First, participants were asked to identify limitations and suggest potential methods to overcome some of the identified limitations. Second, participants were shown examples of existing gaming interventions in published literature and commercial stores. They were also asked to comment on the advantages and limitations of these interventions. Finally, participants were asked if gamification techniques would be appropriate. Results: Overall, 4 health care professionals consented and participated. Several limitations were identified regarding the conventional emotional bias intervention. These included the nature of the task parameters, included stimulus set, and factors that could have an impact on the accuracy of responding to the task. After examining the existing ADHD games, participants raised concerns about the evidence base of some of the apps. They articulated that any developed ADHD game ought to identify the specific skill set that was targeted clearly. Regarding gamification strategies, participants preferred economic and performance-based gamification approaches. Conclusions: This study has managed to elucidate health care professionals’ perspectives toward refining a conventional emotional bias intervention for children with ADHD. In view of the repetitiveness of the conventional task, the suggested gamification techniques might help in influencing task adherence and reduce the attrition rates.
·formative.jmir.org·
JMIR Formative Research - An Emotional Bias Modification for Children With Attention-Deficit/Hyperactivity Disorder: Co-design Study
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjtsKL2te-EAxV0vokEHVgGDMUQFnoECCsQAQ&url=https%3A%2F%2Frepository.ubn.ru.nl%2Fbitstream%2Fhandle%2F2066%2F247442%2F247442.pdf%3Fsequence%3D1&usg=AOvVaw0OGmvUQ0dhet7rbPW0Jhms&opi=89978449
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjtsKL2te-EAxV0vokEHVgGDMUQFnoECCsQAQ&url=https%3A%2F%2Frepository.ubn.ru.nl%2Fbitstream%2Fhandle%2F2066%2F247442%2F247442.pdf%3Fsequence%3D1&usg=AOvVaw0OGmvUQ0dhet7rbPW0Jhms&opi=89978449
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjtsKL2te-EAxV0vokEHVgGDMUQFnoECCsQAQ&url=https%3A%2F%2Frepository.ubn.ru.nl%2Fbitstream%2Fhandle%2F2066%2F247442%2F247442.pdf%3Fsequence%3D1&usg=AOvVaw0OGmvUQ0dhet7rbPW0Jhms&opi=89978449
Late Effects of Treatment for Childhood Cancer (PDQ®) - NCI
Late Effects of Treatment for Childhood Cancer (PDQ®) - NCI
Late effects of cancer treatment can cause serious, disabling, and life-threatening chronic health conditions that adversely affect the health of aging childhood cancer survivors. Learn about subsequent neoplasms and the cardiovascular, cognitive, psychosocial, digestive, endocrine, immune, musculoskeletal, reproductive, and urinary late effects of pediatric cancer treatment in this expert-reviewed summary.
·cancer.gov·
Late Effects of Treatment for Childhood Cancer (PDQ®) - NCI
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiO9_Tmtu-EAxVxvokEHQs6CSw4ZBAWegQIFhAB&url=https%3A%2F%2Fodprn.ca%2Fwp-content%2Fuploads%2F2015%2F12%2FADHD-Final-Consolidated-Report_December-21-15.pdf&usg=AOvVaw1qDkIbYX4zO-S_iz3S9aaL&opi=89978449
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiO9_Tmtu-EAxVxvokEHQs6CSw4ZBAWegQIFhAB&url=https%3A%2F%2Fodprn.ca%2Fwp-content%2Fuploads%2F2015%2F12%2FADHD-Final-Consolidated-Report_December-21-15.pdf&usg=AOvVaw1qDkIbYX4zO-S_iz3S9aaL&opi=89978449
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiO9_Tmtu-EAxVxvokEHQs6CSw4ZBAWegQIFhAB&url=https%3A%2F%2Fodprn.ca%2Fwp-content%2Fuploads%2F2015%2F12%2FADHD-Final-Consolidated-Report_December-21-15.pdf&usg=AOvVaw1qDkIbYX4zO-S_iz3S9aaL&opi=89978449
Exploring the Relationship between Adherence to Therapy, Treatment Acceptability, and Clinical Outcomes in Adults with Attention-Deficit/Hyperactivity Disorder: Results from the COMPAS Multicenter Randomized Controlled Trial | Psychotherapy and Psychosomatics | Karger Publishers
Exploring the Relationship between Adherence to Therapy, Treatment Acceptability, and Clinical Outcomes in Adults with Attention-Deficit/Hyperactivity Disorder: Results from the COMPAS Multicenter Randomized Controlled Trial | Psychotherapy and Psychosomatics | Karger Publishers
Abstract. Introduction: Cognitive behavioral therapy and dialectical behavior therapy (DBT) can be effective in treating adults with ADHD, and patients generally consider these interventions useful. While adherence, as measured by attendance at sessions, is mostly sufficient, adherence to therapy skills has not been assessed. Furthermore, the relationship between patient evaluation of therapy effectiveness, treatment adherence, and clinical outcomes is understudied. Objective: This study aimed to examine treatment acceptability and adherence in relation to treatment outcomes in a large randomized controlled trial comparing a DBT-based intervention with a nonspecific active comparison, combined with methylphenidate or placebo. Method: A total of 433 adult patients with ADHD were randomized. Participants reported how effective they found the therapy, and adherence was measured by attendance at therapy sessions and by self-reports. Descriptive, between-groups, and linear mixed model analyses were conducted. Results: Participants rated psychotherapy as moderately effective, attended 78.40–94.37% of sessions, and used skills regularly. The best-accepted skills were sports and mindfulness. Groups receiving placebo and/or nonspecific clinical management rated their health condition and the medication effectiveness significantly worse than the psychotherapy and methylphenidate groups. Improvements in clinical outcomes were significantly associated with treatment acceptability. Subjective (self-reported) adherence to psychotherapy was significantly associated with improvements in ADHD symptoms, clinical global efficacy and response to treatment. Discussion: These results further support the acceptability of DBT for adult ADHD and suggest the need to address adherence to treatment to maximize clinical improvements. Results may be limited by the retrospective assessment of treatment acceptability and adherence using an ad hoc instrument.
·karger.com·
Exploring the Relationship between Adherence to Therapy, Treatment Acceptability, and Clinical Outcomes in Adults with Attention-Deficit/Hyperactivity Disorder: Results from the COMPAS Multicenter Randomized Controlled Trial | Psychotherapy and Psychosomatics | Karger Publishers
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiO9_Tmtu-EAxVxvokEHQs6CSw4ZBAWegQICBAB&url=https%3A%2F%2Fdownloads.asam.org%2Fsitefinity-production-blobs%2Fdocs%2Fdefault-source%2Fguidelines%2Fstimulant-gudie%2Fstud-etd-tables-pc-may-2023.pdf%3Fsfvrsn%3Dc23de635_3&usg=AOvVaw2Yp7Gac9bnCMPBmyLjoDxn&opi=89978449
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiO9_Tmtu-EAxVxvokEHQs6CSw4ZBAWegQICBAB&url=https%3A%2F%2Fdownloads.asam.org%2Fsitefinity-production-blobs%2Fdocs%2Fdefault-source%2Fguidelines%2Fstimulant-gudie%2Fstud-etd-tables-pc-may-2023.pdf%3Fsfvrsn%3Dc23de635_3&usg=AOvVaw2Yp7Gac9bnCMPBmyLjoDxn&opi=89978449
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiO9_Tmtu-EAxVxvokEHQs6CSw4ZBAWegQICBAB&url=https%3A%2F%2Fdownloads.asam.org%2Fsitefinity-production-blobs%2Fdocs%2Fdefault-source%2Fguidelines%2Fstimulant-gudie%2Fstud-etd-tables-pc-may-2023.pdf%3Fsfvrsn%3Dc23de635_3&usg=AOvVaw2Yp7Gac9bnCMPBmyLjoDxn&opi=89978449
implementation speed Archives | The Center for Technology and Behavioral Health
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiO9_Tmtu-EAxVxvokEHQs6CSw4ZBAWegQIExAB&url=https%3A%2F%2Fmedia.emscimprovement.center%2Fdocuments%2FESI_Handbook2125.pdf&usg=AOvVaw3AmCkGWwyIr46--gAcBDd9&opi=89978449
Adult ADHD - Psychiatrist Long Island, Psychiatrist Alternative Long Island | Kyra Sposato NP
Adult ADHD - Psychiatrist Long Island, Psychiatrist Alternative Long Island | Kyra Sposato NP
Identify key symptoms of ADHD, also known as attention deficity hyperactivity disorder. Treatment options in Long Island provided by Kyra Sposato, NP
·ksposato.com·
Adult ADHD - Psychiatrist Long Island, Psychiatrist Alternative Long Island | Kyra Sposato NP
A Pilot Study of a Device and Drug Therapy for ADHD - PMC
Central Stimulant Agent - an overview | ScienceDirect Topics
Attention-deficit/hyperactivity disorder | Nature Reviews Disease Primers
Attention-deficit/hyperactivity disorder | Nature Reviews Disease Primers
Nature Reviews Disease Primers - Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that affects children and adults. In this Primer, Faraone and colleagues...
·nature.com·
Attention-deficit/hyperactivity disorder | Nature Reviews Disease Primers
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjnpe-Dt--EAxW1lYkEHQt0AoAQFnoFCPABEAE&url=https%3A%2F%2Fwww.medicaid.nv.gov%2FDownloads%2Fprovider%2FADHD_Agents_and_Stimulants_2014-0811.pdf&usg=AOvVaw3lKfS3r-qF39zU83XBrMIe&opi=89978449
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjnpe-Dt--EAxW1lYkEHQt0AoAQFnoFCPABEAE&url=https%3A%2F%2Fwww.medicaid.nv.gov%2FDownloads%2Fprovider%2FADHD_Agents_and_Stimulants_2014-0811.pdf&usg=AOvVaw3lKfS3r-qF39zU83XBrMIe&opi=89978449
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjnpe-Dt--EAxW1lYkEHQt0AoAQFnoFCPABEAE&url=https%3A%2F%2Fwww.medicaid.nv.gov%2FDownloads%2Fprovider%2FADHD_Agents_and_Stimulants_2014-0811.pdf&usg=AOvVaw3lKfS3r-qF39zU83XBrMIe&opi=89978449
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjnpe-Dt--EAxW1lYkEHQt0AoAQFnoECHkQAQ&url=https%3A%2F%2Fcdn.neiglobal.com%2Fcontent%2Fcongress%2F2020%2Fpdf-slides%2FCA_ACAD01-adhd-syl.pdf&usg=AOvVaw0TO2HrFkfh2PrU1Cojcme6&opi=89978449
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjnpe-Dt--EAxW1lYkEHQt0AoAQFnoECHkQAQ&url=https%3A%2F%2Fcdn.neiglobal.com%2Fcontent%2Fcongress%2F2020%2Fpdf-slides%2FCA_ACAD01-adhd-syl.pdf&usg=AOvVaw0TO2HrFkfh2PrU1Cojcme6&opi=89978449
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjnpe-Dt--EAxW1lYkEHQt0AoAQFnoECHkQAQ&url=https%3A%2F%2Fcdn.neiglobal.com%2Fcontent%2Fcongress%2F2020%2Fpdf-slides%2FCA_ACAD01-adhd-syl.pdf&usg=AOvVaw0TO2HrFkfh2PrU1Cojcme6&opi=89978449
WO2018085256A1 - Effective dosing of a child for the treatment of adhd with methylphenidate - Google Patents
WO2018085256A1 - Effective dosing of a child for the treatment of adhd with methylphenidate - Google Patents
The present invention generally relates to treating attention-deficit disorders (e.g., ADHD) by providing an effective amount of an ADHD-effective agent to a patient in need thereof (e.g., a child).
·patents.google.com·
WO2018085256A1 - Effective dosing of a child for the treatment of adhd with methylphenidate - Google Patents
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjnpe-Dt--EAxW1lYkEHQt0AoAQFnoFCMEBEAE&url=https%3A%2F%2Fstore.samhsa.gov%2Fsites%2Fdefault%2Ffiles%2Fpep21-02-01-004.pdf&usg=AOvVaw0O3Cwg-c7agb9rcCeab127&opi=89978449
A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children - Clinical Therapeutics
A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children - Clinical Therapeutics
The limitations of current US Food and Drug Administration (FDA)–approved medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) set the need for the development of novel, effective, and tolerable medications to treat this disorder. The purpose of this study was to evaluate whether treatment with SPN-812 (viloxazine extended-release) significantly reduces symptoms of ADHD in children.
·clinicaltherapeutics.com·
A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children - Clinical Therapeutics
Natural Treatment PCOS: 30 Ways to Help Hormones, Insulin, and More
Natural Treatment PCOS: 30 Ways to Help Hormones, Insulin, and More
There are ways to address the symptoms of polycystic ovary syndrome, or PCOS, through lifestyle changes and dietary supplements, but there’s no one-size-fits-all approach to treatment. Natural treatments include a mix of food modifications, stress management techniques, and more. Here are tips and tricks to consider.
·healthline.com·
Natural Treatment PCOS: 30 Ways to Help Hormones, Insulin, and More
I'm unprofessional and not detail-oriented -- but I still need to earn a living — Ask a Manager
I'm unprofessional and not detail-oriented -- but I still need to earn a living — Ask a Manager
It's the Thursday "ask the readers" question. I am not a detail-oriented person. I've had jobs where I was responsible for things like making sure that a
·askamanager.org·
I'm unprofessional and not detail-oriented -- but I still need to earn a living — Ask a Manager
Intervention Development Archives | The Center for Technology and Behavioral Health